ADMA BIOLOGICS, INC. : Results of Operations and Financial Condition (form 8-K)

Item 2.02 Results of Operations and Financial Condition.

On January 9, 2020, ADMA Biologics, Inc. issued a press release announcing its preliminary financial results for the three months and year ended December 31, 2019 and provided an update on its recent achievements and upcoming milestones. A copy of the press release is furnished herewith as Exhibit 99.1.*

 Item 9.01 Exhibits.




(d) Exhibits



Exhibit No.   Description
99.1            ADMA Biologics, Inc. Press Release, dated January 9, 2020.

* The information in Item 2.02 of this Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

© Edgar Online, source Glimpses